Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT03589469 · COMPLETED
Trial details
- NCT number
- NCT03589469
- Sponsor
- ADC Therapeutics S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2020-05-24
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.